The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer

NCT01697306 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

A.O.U. Città della Salute e della Scienza

Collaborators